Related Experiment Videos
Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon,
B Coiffier1, T Philip, A K Burnett
1Service d'Hématologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026